TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 6 | 9 | 10 | -17 | -1 | -20 | -2 |
| P | %wins | 100 | 100 | 100 | 0 | 50 | 0 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/14/13 21:30 | 6/12/13 | INNV | Innovus Pharmaceuticals, Inc. | NV | Financ | AcqCo | Blank Checks | Damaj Bassam | CA | DOT | P,CEO | P | 135 | 0.3230 | 0 | 417 | 9 | 5,181 | M | ||||||||||||||
2/13/13 19:08 | 2/2/13 | INNV | Innovus Pharmaceuticals, Inc. | NV | Financ | AcqCo | Blank Checks | Damaj Bassam | CA | DOT | P,CEO | P.a | 119 | 0.4752 | 0 | 250 | 6 | 4,764 | D | ||||||||||||||
2/5/13 17:14 | 2/2/13 | INNV | Innovus Pharmaceuticals, Inc. | NV | Financ | AcqCo | Blank Checks | Damaj Bassam | CA | DOT | P,CEO | P | 119 | 0.4752 | 0 | 250 | New | 250 | D | ||||||||||||||
8/23/12 20:32 | 8/21/12 | APRI | Apricus Biosciences, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Damaj Bassam | CA | DO | P,CEO | P | 2 | 2.77 | 0 | 1 | 0 | 1,612 | D | 36 | -31 | -21 | -2 | -17 | -20 | -16 | -4 | 11 | 8 | 8 | -17 | 3 | -19 |
8/21/12 06:03 | 8/20/12 | APRI | Apricus Biosciences, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Damaj Bassam | CA | DO | P,CEO | P | 4 | 2.69 | 0 | 2 | 0 | 1,362 | D | 23 | -32 | -20 | 3 | -17 | -18 | -19 | -9 | 1 | 9 | 11 | -17 | -5 | -20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |